Results 101 to 110 of about 3,462 (201)

A1AT is ineffective on endogenous caspase-1 activation in cell-free system.

open access: yes, 2015
Caspase-1 activity was measured in cell-free lysates from THP-1 monocytes. Cell-free lysates in a hypotonic buffer were placed at 4 or 30°C for 1 hour with or without A1AT (2.5 mg/mL). Same concentration of BSA was used as control. Caspase-1 activity was
Srabani Mitra (259173)   +3 more
core   +1 more source

ROC Analysis of Diagnostic Performance Utilizing Serum Antiproteases in Cancer Patients

open access: yesThe International Journal of Biological Markers, 1988
Assessment of the accuracy of diagnostic procedures is made independent of diagnostic criteria by means of a receiver-operating-characteristics (ROC) curve. We performed ROC analysis for the major serum antiproteases: alpha-1-antitrypsin (A1AT) and alpha-
J. Millán   +6 more
doaj   +1 more source

TEMPORAL AND TISSUE-SPECIFIC EXPRESSION OF THE MET ORF DRIVEN BY THE COMPLETE TRANSCRIPTIONAL UNIT OF HUMAN A1AT GENE IN TRANSGENIC MICE

open access: yes, 1995
We inserted the sequence coding for the cytoplasmic portion of the human MET receptor into an 18-kb genomic fragment containing the entire human A1AT gene (encoding alpha-1-antitrypsin).
AMICONE, Laura   +11 more
core   +1 more source

The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil

open access: yesJornal Brasileiro de Pneumologia
Objective: The clinical, functional, radiological and genotypic descriptions of patients with an alpha-1 antitrypsin (A1AT) gene mutation in a referral center for COPD in Brazil.
Manuela Brisot Felisbino   +5 more
doaj   +1 more source

A1AT does not influence IL-18 processing and release through the activation of caspase-1.

open access: yes, 2015
THP-1 cells and human monocytes were pre-treated with A1AT (2.5 mg/mL) for 1 h followed by LPS 1 μg/ml for 30 minutes, and then triggered with ATP 5 mM for another 30 minutes to determine the release of IL-18 and caspase-1.
Srabani Mitra (259173)   +3 more
core   +1 more source

Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency

open access: yesBiologics: Targets & Therapy, 2009
Caitriona McLean*, Catherine M Greene*, Noel G McElvaneyRespiratory Research Division, Dept. Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland; *Each of these authors contributed equally ...
Caitriona McLean   +2 more
doaj  

Effects of alpha1 antitrypsin (A1AT) on lung inflammation and Pseudomonas aeruginosa (PA) load in wild-type mice after 1 day of infection.

open access: yes, 2015
Mice were infected with PA as described in Materials and Methods, and treated at 2 h post PA infection with A1AT. After 1 day of PA infection, mice (n = 6 mice/group) were sacrificed to determine inflammation (A, B, C, D) and PA load (E, F) in ...
Di Jiang (258208)   +4 more
core   +1 more source

Effects of alpha1 antitrypsin (A1AT) on SPLUNC1 protein levels in bronchoalveolar lavage (BAL) fluid of wild-type and ENaC transgenic (Tg) mice after 3 days of infection.

open access: yes, 2015
Mice were infected with Pseudomonas aeruginosa (PA) as described in Materials and Methods, and treated at 2 hr, 1 day and 3 day post PA infection with A1AT.
Di Jiang (258208)   +4 more
core   +1 more source

Effects of alpha1 antitrypsin (A1AT) on lung inflammation and Pseudomonas aeruginosa (PA) load in ENaC transgenic mice after 3 days of infection.

open access: yes, 2015
Mice were infected with PA as described in Materials and Methods, and treated at 2 hr, 1 day and 3 day post PA infection with A1AT. After 3 days of PA infection, mice (n = 6–7 mice/group) were sacrificed to determine inflammation (A, B, C, D) and PA load
Di Jiang (258208)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy